News and Events
This semester, the RPI-Mt. Sinai Center for Engineering and Precision Medicine (CEPM) welcomed the inaugural cohort of students in the center’s Ph.D. program in health sciences engineering jointly offered by RPI and Icahn School of Medicine at Mount Sinai.
The Multi-Organ Approach to Address Diseases Following Estrogen Loss (MODEL) program aims to map the entire biological landscape of menopause
A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic Institute (RPI), the University of Nebraska Medical Center (UNMC), University of Binghamton, and SUNY College of Environmental Science and Forestry.
New research from Rensselaer Polytechnic Institute (RPI) could help shape the future of artificial intelligence by making AI systems less resource-intensive, higher performing, and designed to emulate the human brain.
Artificial intelligence isn’t just about algorithms and automation — it’s rooted in centuries of human fascination with consciousness, creativity, and what it means to be human.
RPI School of Engineering has named R. Helen Zha, Ph.D., as a Dean’s Faculty Fellow, recognizing her exceptional accomplishments in research, education, and service.
Rensselaer Polytechnic Institute’s Georges Belfort, Ph.D., and Steven Cramer, Ph.D., both Institute Professors of Chemical and Biological Engineering, have won the 2025 Bernard M. Gordon Prize for Innovation in Engineering and Technology Education given by the National Academy of Engineering.
Lung cancer is one of the most challenging diseases, making early diagnosis crucial for effective treatment. Fortunately, advancements in artificial intelligence (AI) are transforming lung cancer screening, improving both accuracy and efficiency.
Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology.
Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology.
